Curcumin	NN
inhibits	VBZ
fibrosis-related	JJ
effects	NNS
in	IN
IPF	NN
fibroblasts	NNS
and	CC
in	IN
mice	NNS
following	VBG
bleomycin-induced	JJ
lung	NN
injury	NN
.	.

Idiopathic	JJ
pulmonary	JJ
fibrosis	NN
(	(
IPF	NN
)	)
is	VBZ
a	DT
progressive	JJ
and	CC
typically	RB
fatal	JJ
lung	NN
disease	NN
for	IN
which	WDT
no	DT
effective	JJ
therapy	NN
has	VBZ
been	VBN
identified	VBN
.	.

The	DT
disease	NN
is	VBZ
characterized	VBN
by	IN
excessive	JJ
collagen	NN
deposition	NN
,	,
possibly	RB
in	IN
response	NN
to	TO
dysregulated	VBN
wound	NN
healing	NN
.	.

Mediators	NNS
normally	RB
involved	VBN
in	IN
would	MD
healing	NN
induce	VB
proliferation	NN
of	IN
fibroblasts	NNS
and	CC
their	PRP$
differentiation	NN
to	TO
myofibroblasts	NNS
that	WDT
actively	RB
secrete	VBP
collagen	NN
.	.

Curcumin	NN
,	,
a	DT
polyphenolic	JJ
compound	NN
from	IN
turmeric	JJ
,	,
has	VBZ
been	VBN
shown	VBN
to	TO
exert	VB
a	DT
variety	NN
of	IN
biological	JJ
effects	NNS
.	.

Effects	NNS
on	IN
IPF	NN
and	CC
associated	VBN
cell	NN
types	NNS
remain	VBP
unclear	JJ
,	,
however	RB
.	.

We	PRP
accordingly	RB
tested	VBD
the	DT
ability	NN
of	IN
curcumin	NN
to	TO
inhibit	VB
proliferation	NN
and	CC
differentiation	NN
to	TO
myofibroblasts	NNS
by	IN
human	JJ
lung	NN
fibroblasts	NNS
,	,
including	VBG
those	DT
from	IN
IPF	NN
patients	NNS
.	.

To	TO
further	RB
examine	VB
the	DT
potential	JJ
usefulness	NN
of	IN
curcumin	NN
in	IN
IPF	NNP
,	,
we	PRP
examined	VBD
its	PRP$
ability	NN
to	TO
reduce	VB
fibrosis	NN
in	IN
bleomycin-treated	JJ
mice	NNS
.	.

We	PRP
show	VBP
that	IN
curcumin	NN
effectively	RB
reduces	VBZ
profibrotic	JJ
effects	NNS
in	IN
both	CC
normal	JJ
and	CC
IPF	JJ
fibroblasts	NNS
in	FW
vitro	FW
and	CC
that	IN
this	DT
reduction	NN
is	VBZ
accompanied	VBN
by	IN
inhibition	NN
of	IN
key	JJ
steps	NNS
in	IN
the	DT
transforming-growth-factor-b	JJ
(	(
TGF-b	JJ
)	)
signaling	NN
pathway	NN
.	.

In	FW
vivo	FW
,	,
oral	JJ
curcumin	NN
treatment	NN
showed	VBD
no	DT
effect	NN
on	IN
important	JJ
measures	NNS
of	IN
bleomycin-induced	JJ
injury	NN
in	IN
mice	NNS
,	,
whereas	IN
intraperitoneal	JJ
curcumin	NN
administration	NN
effectively	RB
inhibited	VBD
inflammation	NN
and	CC
collagen	NN
deposition	NN
along	IN
with	IN
a	DT
trend	NN
toward	IN
improved	VBN
survival	NN
.	.

Intraperitoneal	JJ
curcumin	NN
reduced	VBD
fibrotic	JJ
progression	NN
even	RB
when	WRB
administered	VBN
after	IN
the	DT
acute	JJ
bleomycin-induced	JJ
inflammation	NN
had	VBD
subsided	VBN
.	.

These	DT
results	NNS
encourage	VBP
further	JJ
research	NN
on	IN
alternative	JJ
formulations	NNS
and	CC
routes	NNS
of	IN
administration	NN
for	IN
this	DT
potentially	RB
attractive	JJ
IPF	NN
therapy	NN
.	.

